Predilife Records a 148% Revenue Growth in the First Half of 2025
Predilife announces a significant increase in half-yearly revenue while continuing to face financial challenges.
Significant Increase in Revenue
During the first half of 2025, Predilife achieved a revenue of 392,773 euros, marking an increase of 148% compared to 157,900 euros recorded for the same period in 2024. Concurrently, the company recorded deferred income amounting to 388,380 euros, corresponding to firm orders that will be fulfilled in the coming months. This growth is attributed to an increased demand for predictive health assessments, particularly from companies in the luxury, insurance, and distribution sectors.
Challenging Financial Context
Despite the increase in revenue, Predilife operates in a challenging financial environment. The company posted an operating loss of -1,582,652 euros for the first half of 2025, an improvement from -2,122,642 euros for the same period in 2024. Furthermore, the net result stands at -1,887,716 euros compared to -2,359,563 euros the previous year. With a cash reserve of 229,949 euros as of June 30, 2025, the company continues to implement cost reduction measures and is engaging in discussions with investors to secure new funding.
Outlook for the Second Half of 2025
For the second half of 2025, Predilife relies on the seasonality of health campaigns such as Pink October and Movember to maintain growth momentum. The company anticipates continued expansion due to the growing interest in its preventive health solutions. Stéphane Ragusa, CEO of Predilife, emphasizes that the ongoing success of predictive assessments, supported by customer satisfaction, is promising for the future development of the company. The complete semi-annual financial report will be available by October 31, 2025, on the Predilife website.
